Replies to post #40127 on Medizone Intl. (fka MZEIQ)

[jackcross18]

I know Regulatory approval is right around the corner--EM said so------in 2009

Considering MZEI was "two weeks away" from Groundel funding for about 5 years, the timeline seems about right.


This level of efficacy has stopped new cases of HAI in their tracks, as demonstrated in a number of Canadian hospitals through the collection of accumulated data. 11 months without a single new MRSA infection at Belleville General and 5 months as of June 2015, for C-difficile at Trenton Memorial as examples.

Correct me if I'm wrong but this seems to be the first time the company publically acknowledged the use of AS in this outbreak. Remembering posting my hopes of its use in the VRE outbreak below

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=116429942

One can only wonder how much higher the share price would be if the company provided real time updates as to what they are doing, such as the C-difficile testing and the 3rd generation machines, instead of dumping out a blurb right before christmas. What are we paying Pentony for anyway.


HELLO MZEI, ANYBODY HOME !!!!!!!